{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:54:14Z","timestamp":1761972854503,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study was to investigate the characteristics and outcomes of patients receiving renal replacement therapy for end-stage kidney disease (ESKD) secondary to haemolytic uraemic syndrome (HUS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included all patients with ESKD who commenced renal replacement therapy in Australia and New Zealand between 15\/5\/1963 and 31\/12\/2010, using data from the ANZDATA Registry. HUS ESKD patients were compared with matched controls with an alternative primary renal disease using propensity scores based on age, gender and treatment era.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 58422 patients included in the study, 241 (0.4%) had ESKD secondary to HUS. HUS ESKD was independently associated with younger age, female gender and European race. Compared with matched controls, HUS ESKD was not associated with mortality on renal replacement therapy (adjusted hazard ratio [HR] 1.14, 95% CI 0.87-1.50, p\u2009=\u20090.34) or dialysis (HR 1.34, 95% CI 0.93-1.93, p\u2009=\u20090.12), but did independently predict recovery of renal function (HR 54.01, 95% CI 1.45-11.1, p\u2009=\u20090.008). 130 (54%) HUS patients received 166 renal allografts. Overall renal allograft survival rates were significantly lower for patients with HUS ESKD at 1 year (73% vs 91%), 5 years (62% vs 85%) and 10 years (49% vs 73%). HUS ESKD was an independent predictor of renal allograft failure (HR 2.59, 95% CI 1.70-3.95, p\u2009&lt;\u20090.001). Sixteen (12%) HUS patients experienced failure of 22 renal allografts due to recurrent HUS. HUS ESKD was not independently associated with the risk of death following renal transplantation (HR 0.92, 95% CI 0.35-2.44, p\u2009=\u20090.87).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HUS is an uncommon cause of ESKD, which is associated with comparable patient survival on dialysis, an increased probability of renal function recovery, comparable patient survival post-renal transplant and a heightened risk of renal transplant graft failure compared with matched ESKD controls.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2369-13-164","type":"journal-article","created":{"date-parts":[[2012,12,3]],"date-time":"2012-12-03T19:02:57Z","timestamp":1354561377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["End-stage kidney disease due to haemolytic uraemic syndrome \u2013 outcomes in 241 consecutive ANZDATA registry cases"],"prefix":"10.1186","volume":"13","author":[{"given":"Wen","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaki","family":"Mohandas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel M","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil V","family":"Badve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Boudville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona G","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn J","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kym M","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,3]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G: Atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 361: 1676-1687. 10.1056\/NEJMra0902814.","journal-title":"N Engl J Med"},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","volume":"10","author":"M Noris","year":"2010","unstructured":"Noris M, Remuzzi G: Thrombotic microangiopathy after kidney transplantation. Am J Transplant. 2010, 10: 1517-1523. 10.1111\/j.1600-6143.2010.03156.x.","journal-title":"Am J Transplant"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJM199508103330608","volume":"333","author":"TG Boyce","year":"1995","unstructured":"Boyce TG, Swerdlow DL, Griffin PM: Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med. 1995, 333: 364-368. 10.1056\/NEJM199508103330608.","journal-title":"N Engl J Med"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1056\/NEJM199107113250216","volume":"325","author":"R Begue","year":"1991","unstructured":"Begue R, Dennehy PH, Peter G: Hemolytic uremic syndrome associated with Streptococcus pneumoniae. N Engl J Med. 1991, 325: 133-134.","journal-title":"N Engl J Med"},{"key":"417_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, de KN V, Zimmerhackl LB: A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006, 70: 423-431.","journal-title":"Kidney Int"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","volume":"8","author":"PJ Medina","year":"2001","unstructured":"Medina PJ, Sipols JM, George JN: Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001, 8: 286-293. 10.1097\/00062752-200109000-00004.","journal-title":"Curr Opin Hematol"},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/ndt\/17.7.1228","volume":"17","author":"I Tostivint","year":"2002","unstructured":"Tostivint I, Mougenot B, Flahault A, Vigneau C, Costa MA, Haymann JP, Sraer JD, Rondeau E: Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transplant. 2002, 17: 1228-1234. 10.1093\/ndt\/17.7.1228.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 112","key":"417_CR8","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/ki.2008.609","volume":"75","author":"JN George","year":"2009","unstructured":"George JN: The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989\u20132007). Kidney Int Suppl. 2009, 75 (Suppl 112): S8-S10.","journal-title":"Kidney Int Suppl"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","volume":"3","author":"DR Terrell","year":"2005","unstructured":"Terrell DR, Williams LA, Vesely SK, Lammle B, Hovinga JA, George JN: The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005, 3: 1432-1436. 10.1111\/j.1538-7836.2005.01436.x.","journal-title":"J Thromb Haemost"},{"key":"417_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.94.1.35","volume":"94","author":"RL Siegler","year":"1994","unstructured":"Siegler RL, Pavia AT, Christofferson RD, Milligan MK: A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics. 1994, 94: 35-40.","journal-title":"Pediatrics"},{"key":"417_CR11","first-page":"63","volume":"74","author":"AR Nissenson","year":"1990","unstructured":"Nissenson AR, Port FK: Outcome of end-stage renal disease in patients with rare causes of renal failure III. Systemic\/vascular disorders. Q J Med. 1990, 74: 63-74.","journal-title":"Q J Med"},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/00007890-199805270-00023","volume":"65","author":"D Ducloux","year":"1998","unstructured":"Ducloux D, Rebibou JM, Semhoun-Ducloux S, Jamali M, Fournier V, Bresson-Vautrin C, Chalopin JM: Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis. Transplantation. 1998, 65: 1405-1407. 10.1097\/00007890-199805270-00023.","journal-title":"Transplantation"},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.amjcard.2006.08.042","volume":"99","author":"A Ahmed","year":"2007","unstructured":"Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, Love TE, Aban IB, Shlipak MG: Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007, 99: 393-398. 10.1016\/j.amjcard.2006.08.042.","journal-title":"Am J Cardiol"},{"key":"417_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2307\/2532940","volume":"51","author":"M Lunn","year":"1995","unstructured":"Lunn M, McNeil D: Applying Cox regression to competing risks. Biometrics. 1995, 51: 524-532. 10.2307\/2532940.","journal-title":"Biometrics"},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ: A proportional hazards model for the subdistribution of competing risks in survival analysis. J Am Stat Assoc. 1999, 94: 496-509. 10.1080\/01621459.1999.10474144.","journal-title":"J Am Stat Assoc"},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007, 26: 2389-2430. 10.1002\/sim.2712.","journal-title":"Stat Med"},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.md.0000133622.03370.07","volume":"83","author":"P Coppo","year":"2004","unstructured":"Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, Malot S, Heshmati F, Mira JP, Boulanger E: Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore). 2004, 83: 233-244. 10.1097\/01.md.0000133622.03370.07.","journal-title":"Medicine (Baltimore)"},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","volume":"102","author":"SK Vesely","year":"2003","unstructured":"Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El Harake MA, Raskob GE: ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003, 102: 60-68. 10.1182\/blood-2003-01-0193.","journal-title":"Blood"},{"key":"417_CR19","first-page":"367","volume":"8","author":"C Ponticelli","year":"1977","unstructured":"Ponticelli C, Maestri O, Imbasciati E, Brancaccio D, Rossi E: Late recovery of renal function in a woman with the hemolytic uremic syndrome. Clin Nephrol. 1977, 8: 367-370.","journal-title":"Clin Nephrol"},{"key":"417_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00467-003-1337-4","volume":"19","author":"K Brunner","year":"2004","unstructured":"Brunner K, Bianchetti MG, Neuhaus TJ: Recovery of renal function after long-term dialysis in hemolytic uremic syndrome. Pediatr Nephrol. 2004, 19: 229-231. 10.1007\/s00467-003-1337-4.","journal-title":"Pediatr Nephrol"},{"key":"417_CR21","first-page":"90","volume":"15","author":"H Georgaki-Angelaki","year":"2011","unstructured":"Georgaki-Angelaki H, Stergiou N, Kapogiannis A, Orfanou I, Grapsa B, Roma E: Atypical hemolytic-uremic syndrome (HUS) with recovery after a long-lasting anuria: a case report. Hippokratia. 2011, 15: 90-92.","journal-title":"Hippokratia"},{"key":"417_CR22","first-page":"2","volume":"21","author":"P Kramer","year":"1985","unstructured":"Kramer P, Broyer M, Brunner FP, Brynger H, Challah S, Oules R, Rizzoni G, Selwood NH, Wing AJ, Balas EA: Combined report on regular dialysis and transplantation in Europe, XIV, 1983. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985, 21: 2-65.","journal-title":"Proc Eur Dial Transplant Assoc Eur Ren Assoc"},{"key":"417_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/089686080702700216","volume":"27","author":"AM Craven","year":"2007","unstructured":"Craven AM, Hawley CM, McDonald SP, Rosman JB, Brown FG, Johnson DW: Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int. 2007, 27: 184-191.","journal-title":"Perit Dial Int"},{"key":"417_CR24","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/ndt\/gfp216","volume":"24","author":"JA Macdonald","year":"2009","unstructured":"Macdonald JA, McDonald SP, Hawley CM, Rosman J, Brown F, Wiggins KJ, Bannister K, Johnson DW: Recovery of renal function in end-stage renal failure\u2013comparison between peritoneal dialysis and haemodialysis. Nephrol Dial Transplant. 2009, 24: 2825-2831. 10.1093\/ndt\/gfp216.","journal-title":"Nephrol Dial Transplant"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2215\/CJN.00050505","volume":"1","author":"E Bresin","year":"2006","unstructured":"Bresin E, Daina E, Noris M, Castelletti F, Stefanov R, Hill P, Goodship TH, Remuzzi G: Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol. 2006, 1: 88-99.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-164\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T02:22:04Z","timestamp":1643768524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-164","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"27 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"164"}}